Your browser doesn't support javascript.
loading
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease.
Gorelik, Mark; Chung, Sharon A; Ardalan, Kaveh; Binstadt, Bryce A; Friedman, Kevin; Hayward, Kristen; Imundo, Lisa F; Lapidus, Sivia K; Kim, Susan; Son, Mary Beth; Sule, Sangeeta; Tremoulet, Adriana H; Van Mater, Heather; Yildirim-Toruner, Cagri; Langford, Carol A; Maz, Mehrdad; Abril, Andy; Guyatt, Gordon; Archer, Amy M; Conn, Doyt L; Full, Kathy A; Grayson, Peter C; Ibarra, Maria F; Merkel, Peter A; Rhee, Rennie L; Seo, Philip; Stone, John H; Sundel, Robert P; Vitobaldi, Omar I; Warner, Ann; Byram, Kevin; Dua, Anisha B; Husainat, Nedaa; James, Karen E; Kalot, Mohamad; Lin, Yih Chang; Springer, Jason M; Turgunbaev, Marat; Villa-Forte, Alexandra; Turner, Amy S; Mustafa, Reem A.
Afiliación
  • Gorelik M; Columbia University School of Medicine, New York, New York.
  • Chung SA; University of California, San Francisco.
  • Ardalan K; Duke University School of Medicine, Durham, North Carolina.
  • Binstadt BA; University of Minnesota, Minneapolis.
  • Friedman K; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Hayward K; Seattle Children's Hospital and University of Washington School of Medicine, Seattle, Washington.
  • Imundo LF; Columbia University School of Medicine, New York, New York.
  • Lapidus SK; Joseph M. Sanzari Children's Hospital, Hackensack University Medical Center, and Hackensack Meridian School of Medicine, Hackensack, New Jersey.
  • Kim S; University of California, San Francisco.
  • Son MB; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Sule S; Children's National Hospital, Washington, DC.
  • Tremoulet AH; Rady Children's Hospital and University of California, San Diego, San Diego, California.
  • Van Mater H; Duke University School of Medicine, Durham, North Carolina.
  • Yildirim-Toruner C; Baylor College of Medicine, Houston, Texas.
  • Langford CA; Cleveland Clinic Foundation, Cleveland, Ohio.
  • Maz M; University of Kansas Medical Center, Kansas City.
  • Abril A; Mayo Clinic, Jacksonville, Florida.
  • Guyatt G; McMaster University, Hamilton, Ontario, Canada.
  • Archer AM; Northwestern University, Chicago, Illinois.
  • Conn DL; Emory University, Atlanta, Georgia.
  • Full KA; Springfield, Illinois.
  • Grayson PC; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.
  • Ibarra MF; Children's Mercy Hospital, Kansas City, Missouri.
  • Merkel PA; University of Pennsylvania, Philadelphia.
  • Rhee RL; University of Pennsylvania, Philadelphia.
  • Seo P; Johns Hopkins Medical Institute, Baltimore, Maryland.
  • Stone JH; Massachusetts General Hospital, Boston.
  • Sundel RP; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Vitobaldi OI; Chicago, Illinois.
  • Warner A; Saint Luke's Health System, Kansas City, Missouri.
  • Byram K; Vanderbilt University, Nashville, Tennessee.
  • Dua AB; Northwestern University, Chicago, Illinois.
  • Husainat N; SSM Health St. Mary's Hospital, St. Louis, Missouri.
  • James KE; University of Utah, Salt Lake City.
  • Kalot M; State University of New York at Buffalo.
  • Lin YC; University of South Florida, Tampa.
  • Springer JM; Vanderbilt University, Nashville, Tennessee.
  • Turgunbaev M; American College of Rheumatology, Atlanta, Georgia.
  • Villa-Forte A; Cleveland Clinic Foundation, Cleveland, Ohio.
  • Turner AS; American College of Rheumatology, Atlanta, Georgia.
  • Mustafa RA; University of Kansas Medical Center, Kansas City.
Arthritis Care Res (Hoboken) ; 74(4): 538-548, 2022 04.
Article en En | MEDLINE | ID: mdl-35257507
OBJECTIVE: To provide evidence-based recommendations and expert guidance for the management of Kawasaki disease (KD), focusing on clinical scenarios more commonly addressed by rheumatologists. METHODS: Sixteen clinical questions regarding diagnostic testing, treatment, and management of KD were developed in the Patient/Population, Intervention, Comparison, and Outcomes (PICO) question format. Systematic literature reviews were conducted for each PICO question. We used the Grading of Recommendations, Assessment, Development and Evaluation method to assess the quality of evidence and formulate recommendations. Each recommendation required consensus from at least 70% of the Voting Panel. RESULTS: We present 1 good practice statement, 11 recommendations, and 1 ungraded position statement to guide the management of KD and clinical scenarios of suspected KD. These recommendations for KD are focused on situations in which input from rheumatologists may be requested by other managing specialists, such as in cases of treatment-refractory, severe, or complicated KD. The good practice statement affirms that all patients with KD should receive initial treatment with intravenous immunoglobulin (IVIG). In addition, we developed 7 strong and 4 conditional recommendations for the management of KD or suspected KD. Strong recommendations include prompt treatment of incomplete KD, treatment with aspirin, and obtaining an echocardiogram in the setting of unexplained macrophage activation syndrome or shock. Conditional recommendations include use of IVIG with other adjuvant agents for patients with KD and high-risk features of IVIG resistance and/or coronary artery aneurysms. These recommendations endorse minimizing risk to the patient by using established therapy promptly at disease onset and identifying situations in which adjunctive therapy may be warranted. CONCLUSION: These recommendations provide guidance regarding diagnostic strategies, use of pharmacologic agents, and use of echocardiography in patients with suspected or confirmed KD.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Reumatología / Síndrome Mucocutáneo Linfonodular Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Arthritis Care Res (Hoboken) Asunto de la revista: REUMATOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Reumatología / Síndrome Mucocutáneo Linfonodular Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Arthritis Care Res (Hoboken) Asunto de la revista: REUMATOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos